Rajeev Srivastava

Rajeev Srivastava

Active Director Director DIN 07861590
DIN 07861590 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Mar 2018
Shareholding value •••• Premium profile

About Rajeev Srivastava

Data last updated:

Rajeev Srivastava is a Director at Trounce Life Sciences Private Limited (since 2018) and Additional Director at Shreegen Pharma Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.22 Cr; the largest is Trounce Life Sciences Private Limited at ₹13.02 Cr (FY 2023). Earlier, Rajeev Srivastava was a Director at Nefex Pharma Private Limited (from 2021).

DIN 07861590
Primary Designation Director
Industry Pharma
First Appointment 26 Mar 2018
Oldest Company Age 14 yrs
Largest company Trounce Life Sciences Private Limited · ₹13.02 Cr (FY 2023)
Combined revenue ₹22.22 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Mar 20182018₹13.02 Cr (FY 2023)Active
Shreegen Pharma Limited U24233TG2012PLC083695
Additional Director14 May 20252012₹9.20 Cr (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nefex Pharma Private Limited U24239TG2021PTC148247
Director03 Feb 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rajeev Srivastava

Directorship timeline

Open interactive timeline →
Nefex Pharma Private Limited
Trounce Life Sciences Private Limited
Shreegen Pharma Limited
Premium access

Shareholding and investment profile for Rajeev Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Srivastava

Rajeev Srivastava currently holds 2 directorships: Trounce Life Sciences Private Limited (Director, since 26 Mar 2018, revenue ₹13.02 Cr (FY 2023)); Shreegen Pharma Limited (Additional Director, since 14 May 2025, revenue ₹9.20 Cr (FY 2023)).

Rajeev Srivastava was first appointed on 26 Mar 2018 as Director at Trounce Life Sciences Private Limited. The most recent appointment on record is 14 May 2025 at Shreegen Pharma Limited.

The 2 current companies of Rajeev Srivastava that report revenue have a combined latest revenue of ₹22.22 Cr: Trounce Life Sciences Private Limited ₹13.02 Cr (FY 2023); Shreegen Pharma Limited ₹9.20 Cr (FY 2023).

Rajeev Srivastava held 1 earlier board appointment: Nefex Pharma Private Limited (Director, from 03 Feb 2021).

The current boards of Rajeev Srivastava's companies include Sujatha Tanniru (Trounce Life Sciences Private Limited), Chandra Balireddy Kotthapalli (Shreegen Pharma Limited), Kanaka Nallamilli Sundara Reddy (Shreegen Pharma Limited), Rama Mangeswar Reddy Bobbiti (Shreegen Pharma Limited), Sishtla Ramakrishnan (Shreegen Pharma Limited), Srinivasa Reddy Daka (Shreegen Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available